Heron Therapeutics (HRTX) Capital Expenditures (2010 - 2026)
Heron Therapeutics' (HRTX) quarterly Capital Expenditures came in at $391000.0 in Q1 2026, up 258.72% YoY from $109000.0 in Q1 2025, and up 87.98% on a QoQ basis from $208000.0 in Q2 2025.
Heron Therapeutics (HRTX) Capital Expenditures (2010 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 17 years of Capital Expenditures data on file, last reported at $391000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 258.72% year-over-year to $391000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $599000.0 (down 58.05% YoY) and the FY2025 annual result came in at $317000.0, down 81.42% from the prior year.
- Capital Expenditures rose to $391000.0 in Q1 2026, from $208000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.0 million in Q1 2022 to a low of $45000.0 in Q3 2022.
- A 5-year average of $395923.1 and a median of $322000.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures slumped 97.06% — and 2023, when it jumped 1662.22%.
- Tracing HRTX's Capital Expenditures over 5 years: stood at $414000.0 in 2022, then sank by 39.61% to $250000.0 in 2023, then soared by 155.2% to $638000.0 in 2024, then slumped by 67.4% to $208000.0 in 2025, then surged by 87.98% to $391000.0 in 2026.
- The last three Capital Expenditures figures came in at $391000.0 (Q1 2026), $208000.0 (Q2 2025), and $109000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn | 138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138,000.00 |
| Jun 30, 2026 | 138,000.00 |
| Mar 31, 2026 | 391,000.00 |
| Mar 31, 2026 | 391,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 638,000.00 |
| Dec 31, 2024 | 638,000.00 |
| Sep 30, 2024 | 431,000.00 |
| Sep 30, 2024 | 431,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Sep 30, 2023 | 793,000.00 |
| Sep 30, 2023 | 793,000.00 |
| Jun 30, 2023 | 278,000.00 |
| Jun 30, 2023 | 278,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Mar 31, 2023 | 224,000.00 |